The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers. Kirsten A, Watz H, Pedersen F, Holz O, Smith R, Bruin G, Koehne-Voss S, Magnussen H, Waltz DA Eur Respir J. 2013 Jan; 41(1):239-41. PMID: 23277522. Abstract CommentRecommendBookmarkWatch